MnTnBuOE-2-PyP treatment protects from radioactive iodine (I-131) treatment-related side effects in thyroid cancer

Treatment of differentiated thyroid cancer often involves administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. However, there is morbidity associated with I-131 therapy, which can result in both acute and chronic complications. Currently, there are no approved radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Anery, Kosmacek, Elizabeth A., Fisher, Kurt W., Goldner, Whitney, Oberley-Deegan, Rebecca E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012978/
https://www.ncbi.nlm.nih.gov/pubmed/31728622
http://dx.doi.org/10.1007/s00411-019-00820-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012978/
https://www.ncbi.nlm.nih.gov/pubmed/31728622
http://dx.doi.org/10.1007/s00411-019-00820-2

Ejemplares similares